{"id":118681,"date":"2017-05-26T10:39:04","date_gmt":"2017-05-26T10:39:04","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=118681"},"modified":"2017-05-26T10:39:04","modified_gmt":"2017-05-26T10:39:04","slug":"global-influenza-drugs-and-vaccines-market-forecast-2021-by-vaccinetrivalent-quadrivalent-and-drugszanamivir-oseltamivir-phosphate-peramivir","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/global-influenza-drugs-and-vaccines-market-forecast-2021-by-vaccinetrivalent-quadrivalent-and-drugszanamivir-oseltamivir-phosphate-peramivir_118681.html","title":{"rendered":"Global Influenza Drugs and Vaccines Market Forecast 2021 by Vaccine (Trivalent, Quadrivalent) and Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir)"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Orbis Research”<\/div>\n<\/div>\n<\/div>\n
Global Influenza Drugs and Vaccines Market Research Report 2017 with Primary and Secondary Research is published by Orbis Research.<\/div>\n

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Influenza Market on the basis of Segment Type (Vaccine and Drugs), By Vaccine (Trivalent and Quadrivalent), By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan).<\/p>\n

Browse the report: <\/strong>http:\/\/www.orbisresearch.com\/reports\/index\/global-influenza-drugs-and-vaccines-market-by-drugs-zanamivir-oseltamivir-phosphate-peramivir-by-vaccine-trivalent-quadrivalent-analysis-by-region-by-country-opportunities-and-forecast-2016-2021<\/a><\/p>\n

Rising awareness in relation to influenza virus, surging investment by companies in R&D and increasing number of immunization programmes organized by the government have been some of the factors backing the growth of Global Influenza Market.<\/p>\n

According to Azoth Analytics research report, “Global Influenza Drugs and Vaccines Market-By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent)-Analysis By Region, By Country: Opportunities and Forecast (2016-2021)-By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)”, global market is projected to display a steady growth rate represented by a CAGR of 10.24% during 2017-2022, chiefly driven by increasing spending over various immunization programmes.<\/p>\n

The report titled “Global Influenza Drugs and Vaccines Market-By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent)-Analysis By Region, By Country: Opportunities and Forecast (2016-2021)-By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)”, has covered and analysed the potential of Global Influenza Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global influenza market. Additionally, the report also highlights key development and new drugs launched by various companies across the globe.<\/p>\n

Request a sample of the report: <\/strong>http:\/\/www.orbisresearch.com\/contacts\/request-sample\/299133<\/a><\/p>\n

Scope of the Report<\/strong>
Global Influenza Market
(Actual Period: 2012-2016E, Forecast Period: 2017-2022)
By Segment Type: Influenza Vaccine Market, Influenza Drugs Market
By Vaccine Type: Trivalent, Quadrivalent
By Drug Type: Zanamivi, Oseltamivir Phosphate, Peramivir<\/p>\n

Regional Markets-North America, Europe, APAC, RoW
(Actual Period: 2012-2016E, Forecast Period: 2017-2022)
By Segment Type: Influenza Vaccine Market, Influenza Drugs Market
By Vaccine Type: Trivalent, Quadrivalent
By Drug Type: Zanamivi, Oseltamivir Phosphate, Peramivir<\/p>\n

Country Analysis<\/strong>-US, Canada, UK, Germany, France, Japan, China, India
(Actual Period: 2012-2016E, Forecast Period: 2017-2022)
By Segment Type: Influenza Vaccine Market, Influenza Drugs Market<\/p>\n

Other Report Highlights<\/strong>
Market Dynamics-Trends, Drivers, Challenges
Pipeline Analysis
Company Analysis-Falvogen, Gilead Science and Bio Cryst<\/p>\n

Buy the report@<\/strong>http:\/\/www.orbisresearch.com\/contact\/purchase\/299133<\/a><\/p>\n

Customization of the Report<\/strong>
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.<\/p>\n

Major Points From The Table Of Contents:<\/strong><\/p>\n

Influenza Market: An Introduction<\/p>\n

Global Influenza Market Overview<\/p>\n

Global Influenza Market: Product Analysis<\/p>\n

Global Influenza Vaccines & Drugs – Pipeline Analysis<\/p>\n

Global Influenza Market, Breakdown By Region<\/p>\n

North America Influenza Market: An Analysis<\/p>\n

United States Influenza Market: An Analysis<\/p>\n

Europe Influenza Market: An Analysis<\/p>\n

United Kingdom Influenza Market: An Analysis<\/p>\n

France Influenza Market: An Analysis<\/p>\n

India Influenza Market: An Analysis<\/p>\n

China Influenza Market: An Analysis<\/p>\n

ROW Influenza Market Overview<\/p>\n

Market Dynamics<\/p>\n

Company Profiles<\/p>\n

About Us:<\/strong><\/p>\n

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Orbis Research
Contact Person:<\/strong> Hector Costello
Email:<\/strong> sales@orbisresearch.com
Phone:<\/strong> +1 (214) 884-6817
Address:<\/strong>4144N Central Expressway, Suite 600
City:<\/strong> Dallas
State:<\/strong> Texas
Country:<\/strong> United States
Website:<\/strong> http:\/\/www.orbisresearch.com\/reports\/index\/global-influenza-drugs-and-vaccines-market-by-drugs-zanamivir-oseltamivir-phosphate-peramivir-by-vaccine-trivalent-quadrivalent-analysis-by-region-by-country-opportunities-and-forecast-2016-2021<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Orbis Research” Global Influenza Drugs and Vaccines Market Research Report 2017 with Primary and Secondary Research is published by Orbis Research. A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-118681","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/118681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=118681"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/118681\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=118681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=118681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=118681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}